What Quest Diagnostics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 29 |
| Total trades | 15 | 127 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 22,963 | 272,516 |
| Disposed | 35,277 | 252,876 |
| Net activity | −12,314 | +19,640 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Carter Robert B | Director | Oct 21 | Small Acquisition · L | +10 | $235.93 | +$2.36K | 3,874 |
| Samad Samer Abdul | Executive Vice President & CFO | Oct 21 | Grant / award · A | +90 | $235.94 | +$21.2K | 33,568 |
| Gregg Vicky B | Director | Oct 21 | Grant / award · A | +63 | $235.94 | +$14.9K | 18,449 |
| Kuppusamy Karthik | SVP, Clinical Solutions | Oct 21 | Small Acquisition · L | +33 | $235.94 | +$7.79K | 13,619 |
| Lassiter Wright Iii | Director | Oct 21 | Small Acquisition · L | +6 | $235.96 | +$1.42K | 10,329 |
| Plewman Patrick | SVP for Diagnostic Services | Oct 21 | Small Acquisition · L | +41 | $235.94 | +$9.67K | 15,334 |
| Delaney Mark E | SVP & Chief Commercial Officer | Oct 21 | Small Acquisition · L | +25 | $235.94 | +$5.9K | 10,360 |
| Main Timothy L | Director | Oct 21 | Small Acquisition · L | +18 | $235.94 | +$4.25K | 22,478 |
| Davis J. E. | CEO and President | Sep 01 | Open-market sale · S | −10,000 | $242.72 | −$2.43M | 122,423 |
| Prevoznik Michael E | SVP & General Counsel | Aug 28 | Gift · G | −1,000 | — | — | 36,557 |
| Prevoznik Michael E | SVP & General Counsel | Aug 28 | Open-market sale · S | −430 | $244.51 | −$105K | 37,557 |
| Prevoznik Michael E | SVP & General Counsel | Aug 28 | Open-market sale · S | −6,237 | $243.63 | −$1.52M | 37,987 |
| Prevoznik Michael E | SVP & General Counsel | Aug 28 | Open-market sale · S | −16,010 | $242.88 | −$3.89M | 44,224 |
| Prevoznik Michael E | SVP & General Counsel | Aug 28 | Exercise / conversion · M | +22,677 | $112.17 | +$2.54M | 60,234 |
| Delaney Mark E | SVP & Chief Commercial Officer | Jul 28 | Open-market sale · S | −1,600 | $235.18 | −$376K | 10,335 |
| Lassiter Wright Iii | Director | Jul 22 | Small Acquisition · L | +6 | $206.81 | +$1.24K | 10,323 |
| Delaney Mark E | SVP & Chief Commercial Officer | Jul 22 | Small Acquisition · L | +34 | $206.81 | +$7.03K | 11,935 |
| Samad Samer Abdul | Executive Vice President & CFO | Jul 22 | Grant / award · A | +102 | $206.81 | +$21.1K | 33,478 |
| Main Timothy L | Director | Jul 22 | Small Acquisition · L | +21 | $206.81 | +$4.34K | 22,460 |
| Plewman Patrick | SVP for Diagnostic Services | Jul 22 | Small Acquisition · L | +46 | $206.81 | +$9.51K | 15,293 |
Loading...
